3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Hepatocellular
22
Stomach Neoplasms
20
Carcinoma, Non-Small-Cell Lung
16
Colorectal Neoplasms
9
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Small Cell Lung Carcinoma
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Lymphoma, Extranodal NK-T-Cell
3
Liver Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Renal Cell
3
Carcinoma
3
Nonsquamous Non-Small Cell Lung Cancer
2
Nasopharyngeal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Neuroendocrine
2
Advanced Biliary Tract Cancer
2
Unresectable Locally Advanced Pancreatic Cancer
1
Triple Negative Breast Neoplasms
1
Tislelizumab
1
Thoracic Neoplasms
1
Thoracic Malignancies
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma
1
Respiratory Tract Diseases
1
Recurrent/ Advanced Stage Endometrial Cancer Patients
1
Interventions
toripalimab
1
sintilimab
1
raltitrexed
1
Fluorouracil
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Head and Neck Squamous Cell Cancer
×
sintilimab
×
Clear all
NCT03975270
2019-07-18
HNSCC
ChineseAMS
Phase 2
Unknown
41 enrolled